The Protein Expression of PDL1 Is Highly Correlated with Those of eIF2α and ATF4 in Lung Cancer
Introduction. The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2α)/act...
Saved in:
Published in | Disease markers Vol. 2018; no. 2018; pp. 1 - 9 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Cairo, Egypt
Hindawi Publishing Corporation
01.01.2018
Hindawi John Wiley & Sons, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction. The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2α)/activating transcription factor 4 (ATF4) pathway which in turn regulates the expression of IFN regulatory factor (IRF) 7 and IFNα. The eIF2α/ATF4 pathway is responsible for the integrated stress response (ISR) of unfolded protein response (UPR) which can affect immune cell function in tumor microenvironment. Materials and Methods. The protein levels of PDL1, IRF1, IRF7, STAT1, STAT2, IFNAR1, eIF2α, and ATF4 in the normal and tumor tissues of 27 subjects with lung cancer were determined by Western blot. Results. The protein level of PDL1 was significantly correlated with those of IRF1, eIF2α, and ATF4 in the tissues of all subjects and the subgroup of squamous cell carcinoma but not in the normal tissue of adenocarcinoma. The protein levels of IRF1, eIF2α, and ATF4 were consistently correlated in the tumor tissues but to various extents in the normal ones. The protein level of PDL1 was not correlated with those of STAT1 and STAT2 in all the tissues. Conclusion. The PDL1 expression in lung cancer may be independent of STAT1 and STAT2. The PD1/PDL1 axis and UPR/ISR may be closely associated in the tumor tissues of lung cancer. |
---|---|
AbstractList | The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2α)/activating transcription factor 4 (ATF4) pathway which in turn regulates the expression of IFN regulatory factor (IRF) 7 and IFNα. The eIF2α/ATF4 pathway is responsible for the integrated stress response (ISR) of unfolded protein response (UPR) which can affect immune cell function in tumor microenvironment.INTRODUCTIONThe expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2α)/activating transcription factor 4 (ATF4) pathway which in turn regulates the expression of IFN regulatory factor (IRF) 7 and IFNα. The eIF2α/ATF4 pathway is responsible for the integrated stress response (ISR) of unfolded protein response (UPR) which can affect immune cell function in tumor microenvironment.The protein levels of PDL1, IRF1, IRF7, STAT1, STAT2, IFNAR1, eIF2α, and ATF4 in the normal and tumor tissues of 27 subjects with lung cancer were determined by Western blot.MATERIALS AND METHODSThe protein levels of PDL1, IRF1, IRF7, STAT1, STAT2, IFNAR1, eIF2α, and ATF4 in the normal and tumor tissues of 27 subjects with lung cancer were determined by Western blot.The protein level of PDL1 was significantly correlated with those of IRF1, eIF2α, and ATF4 in the tissues of all subjects and the subgroup of squamous cell carcinoma but not in the normal tissue of adenocarcinoma. The protein levels of IRF1, eIF2α, and ATF4 were consistently correlated in the tumor tissues but to various extents in the normal ones. The protein level of PDL1 was not correlated with those of STAT1 and STAT2 in all the tissues.RESULTSThe protein level of PDL1 was significantly correlated with those of IRF1, eIF2α, and ATF4 in the tissues of all subjects and the subgroup of squamous cell carcinoma but not in the normal tissue of adenocarcinoma. The protein levels of IRF1, eIF2α, and ATF4 were consistently correlated in the tumor tissues but to various extents in the normal ones. The protein level of PDL1 was not correlated with those of STAT1 and STAT2 in all the tissues.The PDL1 expression in lung cancer may be independent of STAT1 and STAT2. The PD1/PDL1 axis and UPR/ISR may be closely associated in the tumor tissues of lung cancer.CONCLUSIONThe PDL1 expression in lung cancer may be independent of STAT1 and STAT2. The PD1/PDL1 axis and UPR/ISR may be closely associated in the tumor tissues of lung cancer. Introduction. The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2 α )/activating transcription factor 4 (ATF4) pathway which in turn regulates the expression of IFN regulatory factor (IRF) 7 and IFN α . The eIF2 α /ATF4 pathway is responsible for the integrated stress response (ISR) of unfolded protein response (UPR) which can affect immune cell function in tumor microenvironment. Materials and Methods. The protein levels of PDL1, IRF1, IRF7, STAT1, STAT2, IFNAR1, eIF2 α , and ATF4 in the normal and tumor tissues of 27 subjects with lung cancer were determined by Western blot. Results. The protein level of PDL1 was significantly correlated with those of IRF1, eIF2 α , and ATF4 in the tissues of all subjects and the subgroup of squamous cell carcinoma but not in the normal tissue of adenocarcinoma. The protein levels of IRF1, eIF2 α , and ATF4 were consistently correlated in the tumor tissues but to various extents in the normal ones. The protein level of PDL1 was not correlated with those of STAT1 and STAT2 in all the tissues. Conclusion. The PDL1 expression in lung cancer may be independent of STAT1 and STAT2. The PD1/PDL1 axis and UPR/ISR may be closely associated in the tumor tissues of lung cancer. Introduction. The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2α)/activating transcription factor 4 (ATF4) pathway which in turn regulates the expression of IFN regulatory factor (IRF) 7 and IFNα. The eIF2α/ATF4 pathway is responsible for the integrated stress response (ISR) of unfolded protein response (UPR) which can affect immune cell function in tumor microenvironment. Materials and Methods. The protein levels of PDL1, IRF1, IRF7, STAT1, STAT2, IFNAR1, eIF2α, and ATF4 in the normal and tumor tissues of 27 subjects with lung cancer were determined by Western blot. Results. The protein level of PDL1 was significantly correlated with those of IRF1, eIF2α, and ATF4 in the tissues of all subjects and the subgroup of squamous cell carcinoma but not in the normal tissue of adenocarcinoma. The protein levels of IRF1, eIF2α, and ATF4 were consistently correlated in the tumor tissues but to various extents in the normal ones. The protein level of PDL1 was not correlated with those of STAT1 and STAT2 in all the tissues. Conclusion. The PDL1 expression in lung cancer may be independent of STAT1 and STAT2. The PD1/PDL1 axis and UPR/ISR may be closely associated in the tumor tissues of lung cancer. The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of transcription (STAT) pathway. The PD1/PDL1 reverse signaling can activate the eukaryotic translation initiation factor 2 (eIF2 )/activating transcription factor 4 (ATF4) pathway which in turn regulates the expression of IFN regulatory factor (IRF) 7 and IFN . The eIF2 /ATF4 pathway is responsible for the integrated stress response (ISR) of unfolded protein response (UPR) which can affect immune cell function in tumor microenvironment. The protein levels of PDL1, IRF1, IRF7, STAT1, STAT2, IFNAR1, eIF2 , and ATF4 in the normal and tumor tissues of 27 subjects with lung cancer were determined by Western blot. The protein level of PDL1 was significantly correlated with those of IRF1, eIF2 , and ATF4 in the tissues of all subjects and the subgroup of squamous cell carcinoma but not in the normal tissue of adenocarcinoma. The protein levels of IRF1, eIF2 , and ATF4 were consistently correlated in the tumor tissues but to various extents in the normal ones. The protein level of PDL1 was not correlated with those of STAT1 and STAT2 in all the tissues. The PDL1 expression in lung cancer may be independent of STAT1 and STAT2. The PD1/PDL1 axis and UPR/ISR may be closely associated in the tumor tissues of lung cancer. |
Author | Kuo, Wei-Ke Chen, Tzu-Ping Chang, Liang-Che Hua, Chung-Ching |
AuthorAffiliation | 3 Division of Pulmonary, Critical Care and Sleep Medicine, Chang Gung Memorial Hospital, Keelung and Chang Gung University, Keelung, Taiwan 2 Division of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital, Keelung and Chang Gung University, Keelung, Taiwan 1 Department of Pathology, Chang Gung Memorial Hospital, Keelung and Chang Gung University, Keelung, Taiwan |
AuthorAffiliation_xml | – name: 2 Division of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital, Keelung and Chang Gung University, Keelung, Taiwan – name: 3 Division of Pulmonary, Critical Care and Sleep Medicine, Chang Gung Memorial Hospital, Keelung and Chang Gung University, Keelung, Taiwan – name: 1 Department of Pathology, Chang Gung Memorial Hospital, Keelung and Chang Gung University, Keelung, Taiwan |
Author_xml | – sequence: 1 fullname: Hua, Chung-Ching – sequence: 2 fullname: Kuo, Wei-Ke – sequence: 3 fullname: Chen, Tzu-Ping – sequence: 4 fullname: Chang, Liang-Che |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30305853$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkcFuEzEQhi1URNPCjTOyxAWphHrW9q73glSlDY0UiR7C2Tje2ayrjR3sDaWPxYvwTDhKKFAJcfEc_M0__8x_Qo588EjIS2DvAKQ8Lxioc8lKVTF4QkagKjlWJWdHZMSKSo1ZIdgxOUnpljEoalE_I8eccSaV5CPyedEhvYlhQOfp1bdNxJRc8DS09OZyDnSW6LVbdf09nYQYsTcDNvTODR1ddCHhjsPZtPjxnRrf0IvFVNAsNN_6FZ0YbzE-J09b0yd8cain5NP0ajG5Hs8_fphNLuZjKyoY8otVjXLZNNAuWw5M1UwYUMCxbU1lkGGDwljFa7W0AtBaKWxT10VZMlQNPyXv97qb7XKNjUU_RNPrTXRrE-91ME7__eNdp1fhqy6hlFKpLPDmIBDDly2mQa9dstj3xmPYJl0AKA4ABWT09SP0Nmyjz-vtKFFC9s4y9epPRw9Wfh0_A2_3gI0hpYjtAwJM77LVu2z1IduMF49w6wYz5LTyPq7_V9PZvqlzvjF37n8jDpYxM9ia3zRILpjkPwFqw7vk |
CitedBy_id | crossref_primary_10_3389_fphar_2021_670900 crossref_primary_10_1016_j_heliyon_2024_e37376 crossref_primary_10_5812_jai_141895 crossref_primary_10_1089_jir_2024_0242 crossref_primary_10_1038_s41598_022_08356_0 crossref_primary_10_1080_1354750X_2022_2102211 crossref_primary_10_1016_j_jbc_2022_101930 crossref_primary_10_1631_jzus_B2200195 crossref_primary_10_3390_ijms20112654 crossref_primary_10_1186_s13046_021_01987_7 crossref_primary_10_1007_s00262_024_03666_w crossref_primary_10_3233_CBM_190828 crossref_primary_10_3389_fonc_2021_734853 crossref_primary_10_1080_2162402X_2021_1962591 |
Cites_doi | 10.1056/NEJMoa1507643 10.1016/j.celrep.2017.04.031 10.1158/1078-0432.CCR-15-1714 10.1038/nature01322 10.1016/j.trecan.2017.11.005 10.1158/1078-0432.CCR-10-1114 10.1038/nrc3239 10.1038/nrm2199 10.1038/sj.cdd.4401373 10.1080/10635150290069913 10.1016/j.immuni.2006.08.009 10.4049/jimmunol.1002240 10.1038/nri3581 10.1016/j.ceb.2017.05.007 10.1056/NEJMoa1504627 10.1038/ni.2762 10.18632/oncotarget.1542 10.1158/1538-7445.AM2017-1704 10.1158/2159-8290.CD-17-0226 10.1128/MCB.14.2.1500 10.1056/NEJMoa1606774 10.1126/scitranslmed.aad7118 10.1146/annurev.immunol.26.021607.090331 10.1126/science.aab4082 10.1038/nature03464 10.1007/s00262-009-0804-6 10.1093/annonc/mdv615 10.1101/cshperspect.a027086 10.1038/gene.2011.21 10.1016/j.ejca.2017.01.011 10.1038/ni1443 10.1016/S0140-6736(15)01281-7 10.18632/oncotarget.7582 10.1038/bjc.1998.528 10.1056/NEJMra1703481 10.1158/1535-7163.MCT-17-0386 10.4161/jkst.27521 10.1016/j.cell.2016.12.004 10.1038/s41388-018-0125-3 10.1007/s10555-016-9652-y |
ContentType | Journal Article |
Copyright | Copyright © 2018 Liang-Che Chang et al. Copyright © 2018 Liang-Che Chang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0 Copyright © 2018 Liang-Che Chang et al. 2018 |
Copyright_xml | – notice: Copyright © 2018 Liang-Che Chang et al. – notice: Copyright © 2018 Liang-Che Chang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0 – notice: Copyright © 2018 Liang-Che Chang et al. 2018 |
DBID | ADJCN AHFXO RHU RHW RHX AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7QO 7TK 8FD C1K FR3 P64 RC3 7X8 5PM |
DOI | 10.1155/2018/5068701 |
DatabaseName | الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete Hindawi Publishing Complete Hindawi Publishing Subscription Journals Hindawi Publishing Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Neurosciences Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Biotechnology Research Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef Genetics Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: RHX name: Hindawi Publishing Open Access url: http://www.hindawi.com/journals/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1875-8630 |
Editor | Gazzaniga, Paola |
Editor_xml | – sequence: 1 givenname: Paola surname: Gazzaniga fullname: Gazzaniga, Paola |
EndPage | 9 |
ExternalDocumentID | PMC6165588 30305853 10_1155_2018_5068701 1153405 |
Genre | Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GrantInformation_xml | – fundername: Chang Gung Memorial Hospital, Linkou grantid: CMRPG2F0521 |
GroupedDBID | --- .GJ 0R~ 24P 29G 36B 4.4 53G 5GY 5RE 5VS AAFNC AAFWJ AAJEY ABDBF ABJNI ABUBZ ACGFS ACIWK ACPQW ACPRK ADBBV ADJCN ADRAZ ADZMO AENEX AFRAH AFRHK AGIAB AHFXO ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CAG COF DIK DU5 EAD EAP EBD EBS EJD EMB EMK EMOBN EPL ESX F5P GROUPED_DOAJ H13 HYE HZ~ IAO IHR IL9 INH INR IOS IPNFZ KQ8 M48 MET MIO O9- OK1 P2P RHX RIG RNS RPM SV3 TUS ZGI ITC RHU RHW AAYXX ACCMX CITATION ACUHS CGR CUY CVF ECM EIF NPM 7QL 7QO 7TK 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY C1K FR3 P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c471t-c4e79e5bdd1fbf3108904a1813effa7ae0ede4ac8398bc41ecc54cd992660e8d3 |
IEDL.DBID | M48 |
ISSN | 0278-0240 1875-8630 |
IngestDate | Thu Aug 21 13:50:46 EDT 2025 Fri Jul 11 08:44:26 EDT 2025 Fri Jul 25 09:30:12 EDT 2025 Wed Feb 19 02:34:21 EST 2025 Tue Jul 01 04:22:15 EDT 2025 Thu Apr 24 22:59:40 EDT 2025 Sun Jun 02 18:54:07 EDT 2024 Tue Nov 26 16:44:34 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2018 |
Language | English |
License | This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c471t-c4e79e5bdd1fbf3108904a1813effa7ae0ede4ac8398bc41ecc54cd992660e8d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Academic Editor: Paola Gazzaniga |
ORCID | 0000-0002-2902-751X |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2018/5068701 |
PMID | 30305853 |
PQID | 2114619040 |
PQPubID | 2046413 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6165588 proquest_miscellaneous_2118311121 proquest_journals_2114619040 pubmed_primary_30305853 crossref_primary_10_1155_2018_5068701 crossref_citationtrail_10_1155_2018_5068701 hindawi_primary_10_1155_2018_5068701 emarefa_primary_1153405 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-01-01 |
PublicationDateYYYYMMDD | 2018-01-01 |
PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Cairo, Egypt |
PublicationPlace_xml | – name: Cairo, Egypt – name: United States – name: Amsterdam |
PublicationTitle | Disease markers |
PublicationTitleAlternate | Dis Markers |
PublicationYear | 2018 |
Publisher | Hindawi Publishing Corporation Hindawi John Wiley & Sons, Inc |
Publisher_xml | – name: Hindawi Publishing Corporation – name: Hindawi – name: John Wiley & Sons, Inc |
References | 22 24 25 26 27 28 29 30 31 10 32 11 33 12 34 13 35 14 36 15 37 16 38 17 39 18 19 1 2 3 4 5 6 7 8 9 40 41 20 21 (23) 2017 |
References_xml | – ident: 5 doi: 10.1056/NEJMoa1507643 – ident: 28 doi: 10.1016/j.celrep.2017.04.031 – ident: 22 doi: 10.1158/1078-0432.CCR-15-1714 – ident: 10 doi: 10.1038/nature01322 – ident: 27 doi: 10.1016/j.trecan.2017.11.005 – ident: 40 doi: 10.1158/1078-0432.CCR-10-1114 – ident: 9 doi: 10.1038/nrc3239 – year: 2017 ident: 23 – ident: 17 doi: 10.1038/nrm2199 – ident: 31 doi: 10.1038/sj.cdd.4401373 – ident: 24 doi: 10.1080/10635150290069913 – ident: 35 doi: 10.1016/j.immuni.2006.08.009 – ident: 18 doi: 10.4049/jimmunol.1002240 – ident: 11 doi: 10.1038/nri3581 – ident: 33 doi: 10.1016/j.ceb.2017.05.007 – ident: 4 doi: 10.1056/NEJMoa1504627 – ident: 12 doi: 10.1038/ni.2762 – ident: 37 doi: 10.18632/oncotarget.1542 – ident: 16 doi: 10.1158/1538-7445.AM2017-1704 – ident: 15 doi: 10.1158/2159-8290.CD-17-0226 – ident: 39 doi: 10.1128/MCB.14.2.1500 – ident: 2 doi: 10.1056/NEJMoa1606774 – ident: 26 doi: 10.1126/scitranslmed.aad7118 – ident: 25 doi: 10.1146/annurev.immunol.26.021607.090331 – ident: 34 doi: 10.1126/science.aab4082 – ident: 19 doi: 10.1038/nature03464 – ident: 29 doi: 10.1007/s00262-009-0804-6 – ident: 7 doi: 10.1093/annonc/mdv615 – ident: 13 doi: 10.1101/cshperspect.a027086 – ident: 36 doi: 10.1038/gene.2011.21 – ident: 41 doi: 10.1016/j.ejca.2017.01.011 – ident: 8 doi: 10.1038/ni1443 – ident: 3 doi: 10.1016/S0140-6736(15)01281-7 – ident: 6 doi: 10.18632/oncotarget.7582 – ident: 30 doi: 10.1038/bjc.1998.528 – ident: 1 doi: 10.1056/NEJMra1703481 – ident: 14 doi: 10.1158/1535-7163.MCT-17-0386 – ident: 20 doi: 10.4161/jkst.27521 – ident: 32 doi: 10.1016/j.cell.2016.12.004 – ident: 38 doi: 10.1038/s41388-018-0125-3 – ident: 21 doi: 10.1007/s10555-016-9652-y |
SSID | ssj0012949 |
Score | 2.2505758 |
Snippet | Introduction. The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and... Introduction. The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and... The expression of programmed death 1 (PD1) and programmed death ligand 1 (PDL1) can be induced by the interferon (IFN)/signal transducer and activator of... |
SourceID | pubmedcentral proquest pubmed crossref hindawi emarefa |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1 |
SubjectTerms | Activating transcription factor 4 Activating Transcription Factor 4 - genetics Activating Transcription Factor 4 - metabolism Adenocarcinoma Apoptosis B7-H1 Antigen - genetics B7-H1 Antigen - metabolism Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Cancer Cancer therapies Carcinoma - genetics Carcinoma - metabolism Cellular stress response Correlation Endoplasmic reticulum Eukaryotic Initiation Factor-2 - genetics Eukaryotic Initiation Factor-2 - metabolism Genes Humans Immune system Immunoglobulins Initiation factor eIF-2 Interferon Interferon regulatory factor 1 Interferon regulatory factor 7 Lung cancer Lung Neoplasms - genetics Lung Neoplasms - metabolism Lymphocytes Mutation PD-1 protein Protein expression Protein folding Proteins Squamous cell carcinoma STAT Transcription Factors - genetics STAT Transcription Factors - metabolism Stat1 protein Stat2 protein Subgroups Tissues Transcription factors Tumors |
SummonAdditionalLinks | – databaseName: Hindawi Publishing Open Access dbid: RHX link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3bjtMwELWg0iJe0HLdsGVlpPKEKuLEbuPHqrRqUUF9aKW-BceeqJW66aoXwX7W_gjfxEzjBlpYwUsuysSJcmyfM_ZkzFhDRVqAs7YpHLYmGeeAbU7qZq61AguKnGiKtvjSGkzlp5ma-SRJmz-n8JHt0D0XyQcVtrBmoZvzEHfklA9m1WRBpEuVG1GyWGSoQ3z7yb1HzHMG1wYPkI7O5uT8flv8TWKeRkr-Rj39c_bEa0beKUF-yh5A8Yw9-uxnxZ-zr4g1H1PChUXBe999aGvBVzkffxwJPtxwCudY3vIurcWxRHnpOA3A8sl8tQGyg2E_-nHHTeF4Z9KXHAsaYTfAu1Qp1i_YtN-bdAdNv3JC0yLZbHELbQ0qc07kWY4KLtGhNEjmMeS5aRsIwYE0FtVRklkpEEclrdMa6TqExMUvWa1YFXDBuDBtaU2kjQBKPRcbVHyZEMYZLFDkKmDvD181tT6tOK1usUz37oVSKWGQegwC9q6yvinTadxj98oD9MsM-2ZUlwFreMD-UUD9gGbqW-UmjegXbFRAMgzY2-oytieaJDEFrHZ7myRGAojoHUrwqwfF1DuivglY-6haVAaUq_v4SrGY73N2t0RLqSR5_X9vf8ke02k51FNnte16B29Q_Gyzq33V_wmT7vlp priority: 102 providerName: Hindawi Publishing |
Title | The Protein Expression of PDL1 Is Highly Correlated with Those of eIF2α and ATF4 in Lung Cancer |
URI | https://search.emarefa.net/detail/BIM-1153405 https://dx.doi.org/10.1155/2018/5068701 https://www.ncbi.nlm.nih.gov/pubmed/30305853 https://www.proquest.com/docview/2114619040 https://www.proquest.com/docview/2118311121 https://pubmed.ncbi.nlm.nih.gov/PMC6165588 |
Volume | 2018 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEB2VolZ9QVyLoa0WqTyhgNfejb0PCFVpoxRaVFAi5c2svWMlUnAgSUX7WfxIv6kzvqSkKkLixbLk8foyMz5ndsczAPs6MBJdlrWkI29SYY7kc8q0cmM0Zqg5iOZsi8_t3kB9HOrhGjTdRusXOL8ztON-UoPZ5O3Fz8sP5PDvS4fXmuJ3Gb_TfptMj-Kg-4RJEfcyOFU36wmBqYhwwPVkCcSaFPhbZ2_BZsgeEOtwBac28LulHQKvjRGHyr_GdxHS23mVfwBV9yE8qBmmOKhM4hGsYfEYNk_rNfQn8I0sQ5xxeYZxIY4u6kTYQkxzcXZ4IsXxXHDyx-RSdLhzx4TIqBM8XSv6o-kcWQ6Pu8HVb2ELJw76XSVooBP6aIgOm9DsKQy6R_1Or1X3WWhlBE0L2mJkUKfOyTzNie_FxleWoD_EPLeRRR8dKpsRl4rTTEnSulaZM4bA3cfYhc9gvZgW-ByEtJHKbGCsRC5UF1rih6mU1lkaUObagzfNW02yugg598KYJGUwonXC6khqdXjwein9oyq-8Re57VpBN2L0JScu6sF-rbB_DLDTaDNpTDAJ-Idt4kvK9-DV8jB5Hy-p2AKn56VMHBJcBHwPlfKXF2osyYNoxSyWAlzZe_VIMR6VFb7bsq11HL_47zNfwhY_XzVXtAPri9k57hJ7WqR7cO_Tl3ivdA_afu0NrwGuKBTW |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Protein+Expression+of+PDL1+Is+Highly+Correlated+with+Those+of+eIF2%CE%B1+and+ATF4+in+Lung+Cancer&rft.jtitle=Disease+markers&rft.au=Chang%2C+Liang-Che&rft.au=Chen%2C+Tzu-Ping&rft.au=Kuo%2C+Wei-Ke&rft.au=Hua%2C+Chung-Ching&rft.date=2018-01-01&rft.pub=Hindawi&rft.issn=0278-0240&rft.eissn=1875-8630&rft.volume=2018&rft_id=info:doi/10.1155%2F2018%2F5068701&rft_id=info%3Apmid%2F30305853&rft.externalDocID=PMC6165588 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0278-0240&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0278-0240&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0278-0240&client=summon |